← Leaderboards
Anand T.n. Kumar
Massachusetts General Hospital
$7,313,344
Attributed
$8,436,451
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2011–25$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,436,451 · 5
By mechanism
R01$8,436,451 · 5
Top collaborators
- Dan Gabriel Duda6 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Joongho Joh$1,322,840
- Zdravka O. Medarova$10,579,501
- Lida P Hariri$6,583,581
- Peter M Sadow$719,248
- Matthias Nahrendorf$28,669,447
Others in their field
Top investigators on “Image”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$332,241,999
- Leonard Freedman · Leidos Biomedical Research, Inc.$321,574,964
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$217,904,052
- Ethan Schreier · Associated Universities, Inc.$206,468,864
Research focus
ImageValidationFluorescenceMalignant NeoplasmsTissuesTumorOpticsCancer CellPre-ClinicalDetectionTranslatingFluorescence ImagingOptical ImagingHistologyImaging TechniquesFluorophoreLabelTomographyAlgorithmsDesignPhysiologicalAngiogenesisMonitorTechnology
Grant awards (21)
Fluorescence lifetime-based intraoperative imaging system for sarcoma surgeries$637,950
R01 · FY2025 · EB · contact PI
Multiplexed time domain fluorescence tomography of tumor biomarkers during immunotherapy$457,001
R01 · FY2025 · CA · contact PI
Fluorescence lifetime-based tumor contrast enhancement using exogenous probes$450,915
R01 · FY2025 · DE · contact PI
Fluorescence lifetime-based tumor contrast enhancement using exogenous probes$456,031
R01 · FY2024 · DE · contact PI
Multiplexed time domain fluorescence tomography of tumor biomarkers during immunotherapy$436,422
R01 · FY2024 · CA · contact PI
Fluorescence lifetime-based tumor contrast enhancement using exogenous probes$565,919
R01 · FY2023 · DE · contact PI
Multiplexed time domain fluorescence tomography of tumor biomarkers during immunotherapy$240,698
R01 · FY2023 · CA · contact PI
Multiplexed time domain fluorescence tomography of tumor biomarkers during immunotherapy$205,000
R01 · FY2023 · CA · contact PI
Fluorescence lifetime-based tumor contrast enhancement using exogenous probes$1
R01 · FY2023 · DE · contact PI
Multiplexed time domain fluorescence tomography of tumor biomarkers during immunotherapy$443,281
R01 · FY2022 · CA · contact PI
Preclinical Time domain Fluorescence Tomography Platform$404,902
R01 · FY2022 · CA · contact PI
Multiplexed time domain fluorescence tomography of tumor biomarkers during immunotherapy$463,813
R01 · FY2021 · CA · contact PI
Preclinical Time domain Fluorescence Tomography Platform$46,659
R01 · FY2021 · CA · contact PI
Preclinical Time domain Fluorescence Tomography Platform$580,767
R01 · FY2020 · CA · contact PI
Preclinical Time domain Fluorescence Tomography Platform$465,244
R01 · FY2019 · CA · contact PI
Preclinical Time domain Fluorescence Tomography Platform$520,559
R01 · FY2018 · CA · contact PI
Preclinical Time domain Fluorescence Tomography Platform$576,080
R01 · FY2017 · CA · contact PI
Fluorescence lifetime tomography of tumor physiology in small animals$374,586
R01 · FY2014 · EB · contact PI
Fluorescence lifetime tomography of tumor physiology in small animals$359,764
R01 · FY2013 · EB · contact PI
Fluorescence lifetime tomography of tumor physiology in small animals$376,352
R01 · FY2012 · EB · contact PI
Fluorescence lifetime tomography of tumor physiology in small animals$374,507
R01 · FY2011 · EB · contact PI